Abstract
To advance the science of tobacco control, an enhanced understanding of the bio-behavioral basis of nicotine addiction is needed. In this study, we provide an overview of data from investigations of genetic factors in smoking behavior, discuss potential bio-behavioral mechanisms and effect modifiers, and suggest avenues for pharmacogenetics research in the area of smoking cessation treatment. The evidence to date is very consistent with respect to the significance of genetic contributions to smoking behavior. However, attempts to elucidate the role of specific genetic variants have met with mixed success. Explanations for the lack of consistency in the results of genetic association studies include biases in ascertainment, ethnic admixture, lack of attention to co-variates or modifiers of genetic risk, and the need for more refined phenotypes. As the field of genetics and smoking research progresses, increasing attention is being devoted to gene–environment interactions, with particular attention to the identification of genetic variants that may modify the effects of pharmacological treatment for smoking. With advances in molecular biology and genomics technology, individualized tailoring of smoking cessation therapy to genotype is within our grasp. Such research has the potential to improve treatment outcome, thereby reducing morbidity and mortality from smoking-related disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
AHCPR. 1996 JAMA 275: 1270–1280
Anda R, Williamson D, Escobedo L, Mast E, Giovino G, Remington P . 1990 J. Am. Med. Assoc. 264: 1541–1545
Arinami T, Ishiguro H, Onaiva E . 2000 Eur. J. Pharmacol. 410: 215–226
Ascher J, Cole J, Colin J . 1995 J. Clin. Psychiatry 56: 395–401
Audrain J, Lerman C, Gomez-Caminero A . 1998 J. Appl. Biobehav. Res. 3: 29–42
Balfour D . 2001 Int. J. Clin. Pract. 55: 53–57
Benjamin J, Li L, Patterson C, Greenberg B, Murphy D, Hamer D . 1996 Nat. Genet. 12: 81
Benowitz N . 1996 Annu. Rev. Pharmacol. Toxicol. 36: 597–613
Bierut L, Rice J, Edenberg H, Goate A, Foroud T, Cloninger C . 2000 Am. J. Med. Genet. 90: 299–302
Blondal T, Franzon M, Westin A . 1997 Eur. Respir. J. 10: 1585–1590
Blondal T, Gudmundsson L, Olafsdottir I, Gustavsson G, Westin A . 1999 BMJ 318: 285–289
Borrelli B, Niaura R, Keuthen N, Goldstein M, Depue J, Murphy C, Abrams D . 1996 J. Clin. Psychiatry 57: 534–538
Breslau N, Kilbey M, Andreski P . 1991 Arch. Gen. Psychiatry 48: 1069–1074
Breslau N, Peterson E, Schultz L, Chilcoat H, Andreski P . 1998 Arch. Gen. Psychiatry 55: 165–166
Caraballo RS, Giovino GA, Pechacek TF, Mowery PD, Richter PA, Strauss WJ, Sharp DJ, Eriksen MP, Pirkle JL, Maurer KR . 1998 J. Am. Med. Assoc. 280: 135–139
Centers for Disease Control and Prevention. 2000 Morbidity and Mortality Weekly Report Number 49
Center for Disease Control . 1994 Morbidity and Mortality Weekly Report Number 43
Cepeda-Benito A . 1993 J. Consult. Clin. Psychol. 61: 822–830
Chassin L, Presson C, Montello D, Sherman S, McGrew J . 1986 Develop. Psychol. 22: 327–334
Choi W, Pierce J, Gilpin E, Farkas A, Berry C . 1997 Am. J. Prev. Med. 13: 385–391
Cinciripini P, Lapitsky M, Seay S, Wallfisch A, Meyer W, Van Vunakis H . 1995 J. Clin. Psychopharmacol. 15: 182–191
Cloninger C . 1987 Arch. Gen. Psychiatry 44: 573–588
Cloninger C . 1994 Curr. Opin. Neurobiol. 4: 266–273
Cloninger C, Svrakic D, Przybeck T . 1993 Arch. Gen. Psychiatry 50: 975–990
Cohen S, Stookey G, Katz B, Drook C, Christen A . 1989 J. Am. Dent. Assoc. 118: 41–45
Comings D, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D . 1996 Pharmacogenetics 6: 73–79
Conrad K, Flay B, Hill D . 1992 Br. J. Addict. 87: 1711–1724
Dale L, Hurt R, Offord K, Lawson G, Croghan I, Schroeder DR . 1995 JAMA 274: 1353–1358
Dani J, Heinemann S . 1996 Neuron 16: 905–908
David S, Niaura R, Shadel W, Britt D, Papandonatos G, Day A, Stumpff J, Hutchison K, Walton R, Murphy M, Johnstone E, Griffiths S . 2001 Presentation of the Society of Research on Nicotine and Tobacco, Seattle, Washington
Davis M, Ramos R . 1999 Psychosom. Med. 61: 84–130
Ebstein R, Nemanov L, Klotz I, Gritsenko I, Belmaker R . 1997 Mol. Psychiatry 2: 472–477
Eissenberg T, Balster R . 2000 Drug Alcohol Depend. 1: S41–S60 Review
Evans N, Farkas A, Gilpin E, Berry C, Pierce JP . 1995 J. Nat. Cancer Inst. 87: 1538–1538
Fiore M, Jorenby D, Baker T, Kenford S . 1992 JAMA 268: 2687–2694
Fiore M, Smith S, Jorenby D, Baker T . 1994 JAMA 271: 1940–1947
Fiore M, Novotny T, Pierce J, Giovino G, Hatziandreu E, Newcomb P, Surawicz T, Davis R . 1990 JAMA 263: 2760–2765
Fiore M . 2000 Respiratory Care 45: 1200–1262
Flay B, d'Avernas J, Best J, Kersell M, Ryan K . 1983 In Pediatric and Adolescent Behavioral Medicine McGrath PJ, Firestone P (eds) New York: Springer-Verlag pp. 132–183
Flory J, Manuck S, Ferrell R, Dent K, Peters D, Muldoon M . 1999 Mol. Psychiatry 4: 93–96
Friedman L, Lichtenstein E, Biglan A . 1985 Addict. Behav. 10: 1–13
Gilbert D, Gilbert B . 1995 Behav. Genet. 25: 133–147
Glassman A, Covey L, Stetner F, Rivelli S . 2001 The Lancet 357: 1929–1932
Hall S, Munoz R, Reus V, Sees K, Duncan C, Humfleet G, Hartz D . 1996 J. Consult. Clin. Psychol. 64: 1003–1009
Hays J, Hurt R, Rigotti N, Niaura R, Gonzales D, Durcan M, Sachs D, Wolter T, Buist A, Johnston J, White J . 2001 Ann. Intern. Med. 135: 423–433
Heath A, Cloninger C, Martin N . 1994 J. Pers. Soc. Psychol. 66: 762–775
Heath A, Kirk K, Meyer J, Martin N . 1999 Behav. Genet. 29: 395–407
Heath A, Martin N . 1993 Addict. Behav. 18: 19–34
Heinz A, Goldman D, Jones D, Palmour R, Hommer D, Gorey J, Leeks S, Linnoila M, Weinbergen DR . 2000 Neuropsychopharmacology 22: 133–139
Henningfield J . 1995 N. Engl. J. Med. 333: 1196–1203
Henningfield J, Keenan R . 1993 J. Consult. Clin. Psychol. 61: 743–750
Hiatt R, Rimer B . 1999 Cancer Epidemiol. Biomarkers Prev. 8: 957–964
Hilleman D, Mohiuddin S, Delcore M . 1994 J. Clin. Pharmacol. 34: 222–224
Hjalmarson A, Franzon M, Westin A, Wiklund O . 1994 Arch. Intern. Med. 154: 2567–2572
Hu S, Brody C, Fisher C, Gunzerath L, Nelson M, Sabol S, Sirota LA, Marcus SE, Greenberg BD, Murphy DL, Hamer DH . 2000 Mol. Psychiatry 5: 181–188
Hughes J . 1986 Behavior. Therapy 17: 335–345
Hughes J . 1993 J. Consult. Clin. Psychol. 61: 751–760
Hughes J, Lesmes G, Hatsukami D, Richmond R, Lichtenstein E, Jorenby D, Broughton J, Fortmann S, Leischow S, McKenna J, Rennard S, Wadland W, Heatley S . 1999 Nicotine Tob. Res. 1: 169–174
Hurt R, Sachs D, Glover E, Offord K, Johnston J, Dale L, Khayrallah MA, Schoeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM . 1997 N. Engl. J. Med. 337: 1195–1202
Hutchison K, LaChance H, Niaura R, Bryan A, Smolen A . 2002 J. Abnorm. Psychology 111: 134–143
Jorenby D, Smith S, Fiore M, Hurt R, Offord K, Croghan I, Hays J, Lewis S, Baker T . 1995 JAMA 274: 1347–1352
Jorenby D, Leischow S, Nides M, Rennard S, Johnston J, Hughes A, Smith S, Muramoto M, Daughton D, Doan K, Fiore M, Baker T . 1999 N. Engl. J. Med. 340: 685–691
Jorm A, Henderson A, Jacomb P, Christensen H, Korten A, Rodgers B, Tan X, Esteal S . 2000 Am. J. Med. Genet. 96: 331–334
Kandel D, Huang F, Davies M . 2001 Drug Alcohol Depend. 64: 233–241
Kendler K, Neale M, Sullivan P, Corey LA, Gardner CO, Prescott GA . 1999 Psychol. Med. 29: 299–308
Kenford S, Fiore M, Jorenby D, Smith S, Wetter D, Baker T . 1994 JAMA 271: 589–594
Killen J, Fortmann S, Kraemer H, Varady A, Davis L, Newman B . 1996 J. Consult. Clin. Psychol. 64: 1060–1067
King G . 1997 Soc. Sci. Med. 45: 1075–1087
King TK, Borelli B, Black C, Pinto BM, Marcus BH . 1997 Ann. Behav. Med. 19: 301–313
Lando H, Pirie P, Roski J, McGovern P, Schmid L . 1996 Am. J. Public Health 86: 1786–1790
Lasser K, Boyd J, Woolhandler S, Himmelstein D, McCormick D, Bor D . 2000 JAMA 284: 2606–2610
Lerman C, Shields P, Audrain J, Main D, Cobb B, Boyd N, Caporason N . 1998 Cancer Epidemiol. Biomarkers Prev. 7: 253–255
Lerman C, Caporaso N, Audrain J, Main D, Boyd N, Shields P . 2000 Mol. Psych. 5: 189–192
Lerman C, Caporaso N, Bush A, Zheng Y, Audrain J, Main D, Shields P . 2001 American J. Med. Genet. 105: 518–520
Lerman C, Audrain J, Main D, Boyd N, Caporaso N, Bowman E, Lockshin B, Shields P . 1999 Health Psychol. 18: 14–20
Lesch K, Bengel D, Heils A, Sabol S, Greenberg B, Petri S, Benjamin J, Muller C, Hamer DH, Murphy DL . 1996 Science 274: 1527–1531
Lipkus I, Barefoot J, Williams R, Siegler I . 1994 Health Psychol. 13: 149–155
London S, Idle J, Daly A, Coetzee G . 1999 Lancet 353: 898–899
Madden P, Heath A, Pedersen N, Kaprio J, Koskenvuo M, Martin N . 1999 Behav. Genet. 29: 423–431
Malhotra A, Virkkunen M, Rooney W, Eggert M, Linnoila M, Goldman D . 1996 Mol. Psychiatry 1: 388–391
Manuck S, Flory J, Ferrell R, Dent K, Mann J, Muldoon M . 1999 Biol. Psychiatry 45: 603–614
Masse L, Tremblay R . 1997 Arch. Gen. Psychiatry 54: 62–68
McKinney E, Walton R, Yudkin P, Fuller A, Haldar N, Mant D, Murphy M, Welsh K, Marshall S . 2000 Pharmacogenetics 10: 483–491
Nelson DE, Giovino GA, Shopland DR, Mowery PD, Mills SL, Eriksen MP . 1995 Am. J. Public Health 85: 34–45
Niaura R, Britt D, Shadel W, Goldstein M, Abrams D, Brown R . 2001 Psychol. Addict. Behav. 15: 13–17
Niaura R, Spring B, Borrelli B, Hedeker D, Goldstein M, Keuthen N, DePue J, Kristeller J, Ockene J, Prochazka A, Chiles J, Abrams D . 2002 J. Consult. Clin. Psychol. in press
Nielsen D, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M . 1994 Arch. Gen. Psychiatry 51: 34–38
Noble E . 2000 Pharmacogenomics 1: 309–333
Noble E, St Jeor S, Ritchie T, Syndulko K, St Jeor S, Fitch R, Brunner RL, Sparkes RS . 1994 Med. Hypotheses 42: 257–260
Ockene J . 1993 Ann. Behav. Med. 15: 135–148
Noble E, Ozkaragoz T, Ritchie T, Zhang X, Belin T, Sparkes R . 1998 Am. J. Med. Genet. 81: 257–267
Orleans C, Schoenbach V, Wagner E, Quade D, Salmon M, Pearson D, Fiedler J, Porter C, Kaplan B . 1991 J. Consult. Clin. Psychol. 59: 439–448
Oscarson M, Gullsten H, Rautio A, Bernal M, Sinues B, Dahl M, Stengard JH, Pelkonen O, Raunio H, Ingelman-Sundberg M . 1998 FEBS Lett. 438: 201–205
Paoletti P, Fornai E, Maggiorelli F, Puntoni R, Viegi G, Carrozzi L, Corlando A, Gustavsson G, Säwe U, Giuntini C . 1996 Eur. Respir. J. 9: 643–651
Perez-Stable E, Marin G, Marin B, Katz M . 1990 Am. J. Public Health 80: 1500–1502
Perkins K . 2001 CNS Drugs 15: 391–411
Perkins K . 1996 Exp. Clin. Psychopharmacol. 4: 166–177
Perkins K . 1999 Pharmacol. Biochem. Behav. 64: 295–299
Pianezza M, Sellers E, Tyndale R . 1998 Nature 393: 750
Pickworth W, Fant R, Butschky M, Henningfield J . 1996 J. Pharmacol. Exp. Ther. 279: 450–456
Pierce JP, Gilpin EA, Choi WS . 1999 Tobacco Control 8: 37–44
Pierce JP, Gilpin E, Burns DM, Whalen E, Rosbrook B, Shopland D, Johnson M . 1991 J. Am. Med. Assoc. 266: 3154–3158
Piper M, Fox BJ, Welsch SK, Fiore MC, Baker TB . 2001 Nicotine and Tobacco Research 3: 291–298
Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami D, Allen S, Lando H . 1992 Am. J. Public Health 82: 1238–1243
Pomerleau C, Pomerleau O, Flessland K, Basson S . 1992 J. Subst. Abuse 4: 143–154
Pomerleau CS, Pomerleau OF, Namenek RJ, Marks JL . 1999 J. Add. Dis. 18: 13–19
Pomerleau O . 1998 Psychoneuroendocrinology 2: 115–130
Rigotti N, Lee J, Wechsler H . 2000 JAMA 284: 699–705
Royce JM, Corbett K, Sorensen G, Ockene J . 1997 Soc. Sci. Med. 44: 359–370
Sabol S, Nelson M, Fisher C, Gunzerath L, Brody C, Hu S, Sirota LA, Marcus SE, Greenberg BP, Lucas FS, Benjamin J, Murphy DL, Hamer DH . 1999 Health Psychol. 18: 7–13
Sargent J, Dalton M, Beach M . 2000 Tobacco Control 9: 163–168
Schneider N, Olmstead R, Steinberg C, Sloan K, Daims R, Brown H . 1996 Clin. Pharmacol. Ther. 60: 568–575
Schneider N, Olmstead R, Mody F, Doan K, Franzon M, Jarvik M, Steinberg C . 1995 Addiction 90: 1671–1682
Shields P, Lerman C, Audrain J, Main D, Boyd N, Caporaso N . 1998 Cancer Epidemiol. Biomarkers Prev. 7: 453–458
Shiffman S, Johnston J, Khayrallah M, Elash C, Gwaltney C, Paty J, Gnys M, Evoniuk G, DeVeaugh-Geiss J . 2000 Psychopharmacology (Berl) 148: 33–40
Silagy C, Mant D, Fowler G, Lodge M . 1994 Lancet 343: 139–142
Silverman M, Neale M, Sullivan P, Harris-Kerr C, Wormley B, Sadek H, Ma K, Kendler KS, Straub RE . 2000 Am. J. Med. Genet. (Neuropsych. Genet.) 96: 646–653
Son B, Markovitz J, Winders S, Smith D . 1997 Am. J. Epidemiology 145: 110–116
Spitz M, Shi H, Yang F, Hudmon K, Jiang H, Chamberlain R . 1998 J. Natl. Cancer Inst. 90: 358–363
Stallings M, Hewitt J, Cloninger C, Heath A, Eaves L . 1996 J. Pers. Soc. Psychol. 70: 127–140
Stapleton JA, Russel MA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Wiseman D . 1995 Addiction 90: 31–42
Sullivan P, Kendler K . 1999 Nicotine Tob. Res. 1: S51–S57
Sullivan P, Jiang Y, Neale M, Kendler K, Straub R . 2001 Am. J. Med. Genet. 105: 479–484
Sutherland G, Stapleton J, Russell M, Jarvis M, Hajek P, Belcher M, Feyerabend C . 1992 Lancet 340: 324–329
Tang J, Law M, Wald N . 1994 BMJ 308: 21–26
Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F . 1993 JAMA 269: 1268–1271
Transdermal Nicotine Study Group. 1991 JAMA 266: 3133–3138
TRIP. 1998 Tobacco Research Implementation Plan, National Cancer Institute. Tobacco Research Implementation Group
True W, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC, Eisen SA, Lyons MJ, Goldberg J, Tsuang M . 1999 Arch. Gen. Psychiatry 56: 655–661
USDHHS (US Department of Health and Human Services). 1998 Surgeon General's Report Washington, DC: U.S. Government Printing
Vandenbergh D, Zonderman A, Wang J, Uhl G, Costa PJ . 1997 Mol. Psychiatry 2: 417–419
Vandenbergh D, Bennett C, Grant M, Strasser A, O'Connor R, Stauffer R, Vogler G, Kozlowski L . 2002 Nicotine Tob. Res. in press
Voorhees CC, Stillman FA, Swank RT, Heagerty PJ, Levine DM, Becker DM . 1996 Prev. Med. 25: 277–285
Wacholder S, Rothman N, Caporaso N . 2000 J. Natl. Cancer Inst. 92: 1151–1158
Walton R, Johnstone E, Munafo M, Neville M, Griffiths S . 2001 Trends Mol. Med. 7: 70–75
Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB . 1999 J. Counsel. Clin. Psychol. 67: 555–562
Wills T, Vaccaro D, McNamara G . 1994 J. Subst. Abuse 6: 1–20
Acknowledgements
The authors would like to thank Freda Patterson, M.A. and Maryanne Foster for their assistance in the preparation of this manuscript. Supported by grants from the National Cancer Institute (P50 CA84718), RO1 CA63562 (C Lerman), and P50CA084719 (R Niaura), and the National Heart Lung and Blood Institute RO1 HL32318 (R Niaura).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
This article is cited by
-
Association of functional COMT Val108/Met polymorphism with smoking cessation in a nicotine replacement therapy
Journal of Neural Transmission (2012)
-
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch
The Pharmacogenomics Journal (2008)
-
Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials
Neuropsychopharmacology (2006)
-
Genetic susceptibility to substance dependence
Molecular Psychiatry (2005)